Starton Therapeutics Inc says poised for Phase 2 dose-optimization study following FDA clearance of IND application for STAR-OLZ
Starton Therapeutics Inc has reported that the US Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for candidate...